• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Lansoprazole
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    LANSO TEVA 30 mg
    Teva Israel LTD, Israel
    RX
    not in the basket chart
    LANSO TEVA 30 mg

    Lansoprazole 30 mg.
    Gatro res. caps. 28 X 30 mg
    1-2 caps/day for adults and adolesc. aged 12-17
    Tmt. of duodenal and gastric ulcer/Tmt. of reflux oesophagitis/

    Prophyl. of reflux oesophagitis/ Eradic. of H. pylori concurr. given with  antibiotic ther. for tmt. of H.pylori-assoc. ulcers/
    Tmt. of NSAID-assoc. benign gastric and duodenal ulcers in pts. req.continued NSAID tmt./
    Prophyl. of NSAID-assoc. gastric ulcers and duodenal ulcers in pts. at risk req. continued ther/ Symptom. gastroesophageal reflux dis./
    Zollinger-Ellison syndr.
    C/I:
     Hypersens. Concom. use with rilpivirine

    Lansoprazole Teva
    Teva
    RX
    partial basket chart
    Lansoprazole Teva

    PPI. Lansoprazole 30 mg.
    CAPS: 30 x 30 mg. Duod. ulc: 30
    mg 1 x dly for 4 wks. Prevent. relapse:
    15 mg 1 x dly. Benign gastric ulc: 30 mg
    1 x dly for 8 wks. GERD: 30 mg 1 x dly for
    4 wks. If not fully healed, cont. for 4 wks
    at same dose. Long-term main: 15/30
    mg 1 x dly. All in morn. bef. food. Erad.
    H. pylori: 30 mg 2 x dly (morn. and
    even.) plus 2 of follow. antibiots:
    clarithromycin 250 mg 2 x dly,
    amoxicillin 1 g 2 x dly, or metrinodazole
    400 mg 2 x dly for 7 days. Tmt., proph.
    NSAID-assoc. benign gastric ulc., duod.
    ulc., relief sympts in pts req. cont. NSAID
    tmt: 15/30 mg 1 x dly.
    Tmt. duod. ulc., benign gastric. ulc., GERD,
    acid related disords upper GI tract. Heal.,
    long term tmt. and maint. ther. for pts.
    with GERD or duod. ulc. Prev. relapse in pts
    with GERD or duod. ulc. Erad. H. Pylori
    from upper GI tracts in pts with duod. ulc.,
    gastrit., benign ulc. (in comb. with approp.
    antibiotics). Short term tmt. (up to 4 wks)
    heartburn and/or upper epigast. pain
    assoc. with acid-related dyspeps. Longterm
    manag. path. hypersecret. conds,
    incl. Zollinger Ellison syndr. Tmt., proph. of
    NSAID assoc. benign gastric ulc., duod.
    ulc., relief sympts. in pts. req. cont. NSAID
    tmt.
    C/I: Hypersens., pregn.

    Lanton
    Rafa
    RX
    partial basket chart
    Lanton

    PPI. Lansoprazole 15 mg, 30 mg.
    CAPS: 28. Duod. ulc: 30 mg 1 x dly for 4
    wks. Maint: To prevent relapse: 15 mg 1 x
    dly. Benign gastric. ulc: 30 mg 1 x dly for 8
    wks. GERD: 30 mg 1 x dly for 4 wks. If
    needed, 4 wks more. Maint: 15-30 mg.
    GERD: 30 mg (or 15 mg in some
    individuals) 1 x dly for 4 wks. If not
    alleviated, further investigations
    recommended. Maint: 15 mg 1 x dly. Erad.
    H. pylori: 30 mg 2 x dly with antibiotics as
    in med. lit. Zollinger Ellison synd./other
    hypersecretory cond: 2 x 30 mg 1 x dly.
    Adjust per individual as long as necess. Up
    to 180 mg dly have been used. If the req.
    dly dose is greater than 120 mg, div. into 2
    dly doses. NSAID-assoc. benign gastric
    ulc., duod. ulc., relief sympts. in cont.
    NSAID tmt: 15-30 mg 1 x dly for 4 wks. If
    necess. 4 wks more. Pts at risk or with
    refract. ulc., longer tmt. and/or poss.
    higher dose. Elderly: No adjust. reqd.
    Pediatric: No experience.
    Duod. ulc., benign gastric ulc., GERD,
    erad. H. pylori; Zollinger Ellison synd/
    other hypersecretory conds, NSAIDassoc.
    benign gastric ulc., duod. ulc.,
    relief sympts. in cont. NSAID tmt.
    C/I: Pregn..

    CLOSE